Aug 12, 2024, 17:22 by Stuart Gitlow, MD, MPH, MBA, DFAPA, DFASAM

By now, addiction specialists understand the depth and impact of the drug overdose death crisis in the United States. We’ve read that, “Drug overdoses are one of the leading causes of injury death in adults and have risen over the past several decades… In 2022, 107,941 drug overdose deaths occurred.” Studies published in the past year alone highlight the toll overdose is taking on communities and families, with health disparities and inequities in care often exacerbating negative health outcomes for those most in need.

Aug 8, 2024, 08:47 by Molly McGrath

Aug 7, 2024, 13:39 by ASAM Weekly Editors

Rapid Initiation of Injectable Extended-Release Naltrexone for Opioid Use Disorder: A Time for Paradigm Shift in Treatment Protocols

Aug 5, 2024, 16:21 by Stuart Gitlow, MD, MPH, MBA, DFAPA, DFASAM

The opioid crisis remains a critical public health issue in the United States, contributing to over 80,000 opioid overdose deaths in 2023 alone.

Aug 5, 2024, 14:52 by Kelly Corredor

Jul 31, 2024, 12:53 by ASAM Weekly Editors

Guest Editorial: Does Rescheduling Cannabis Make Sense?

Jul 30, 2024, 17:50 by Kelly Corredor

CMS publishes important 2025 proposals for Addiction Medicine.

Jul 30, 2024, 13:54 by Stuart Gitlow, MD, MPH, MBA, DFAPA, DFASAM

On May 16, the Department of Justice (DOJ) proposed moving marijuana from Schedule I to Schedule III of the Controlled Substances Act. Between now and November’s election, there will be considerable discussion regarding rescheduling.

Jul 24, 2024, 13:26 by ASAM Weekly Editors

Guest Editorial: To Address the Fentanyl Crisis, Greater Access to Methadone Is Needed

Jul 22, 2024, 17:31 by Kelly Corredor

Jul 22, 2024, 15:20 by By Nora D. Volkow, MD

Over the past several years, the increasing prevalence of fentanyl in the drug supply has created an unprecedented overdose death rate and other devastating consequences.

Jul 22, 2024, 00:00 by ASAM Weekly Editors

Jul 19, 2024, 14:43 by Kelly Corredor

ASAM comments on marijuana rescheduling proposal.

Jul 17, 2024, 13:52 by ASAM Weekly Editors

Benzodiazepine use in relation to long-term dementia risk

Jul 11, 2024, 14:05 by ASAM Weekly Editors

Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial

Jul 5, 2024, 16:54 by ASAM Weekly Editors

Global status report on alcohol and health and treatment of substance use disorders

Jul 5, 2024, 16:28 by Molly McGrath

ASAM Advocacy has developed seven fundamental tips for op-ed writing to assist members.

Jun 27, 2024, 17:00 by Molly McGrath

Twenty four organizations signed a letter, spearheaded by Mental Health America, requesting $40 million for the Employee Security Benefits Administration (EBSA) within the Department of Labor (DOL) in the FY 2025 Labor-Health and Human Services (HHS) appropriations bill to review health plans' parity compliance analyses.

Jun 27, 2024, 06:45 by ASAM Weekly Editors

Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths

Jun 26, 2024, 13:39 by Molly McGrath

ASAM joined a letter signed by 40 organizations requesting the Departments of Health and Human Services, Labor, and Treasury finalize the 2023 proposed parity regulations.